The CLARITY Trial Lead by Dr. Hillmen  Feasibility study that looked at efficacy of Ibrutnib and Venetolax in RR-CLL

The CLARITY Trial Lead by Dr. Hillmen Feasibility study that looked at efficacy of Ibrutnib and Venetolax in RR-CLL

User Photo
moasc

2 years
73 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Ann Eapen Division of Hematology/Oncology: UC Irvine discusses The CLARITY Trial Lead by Dr. Hillmen Feasibility study that looked at efficacy of Ibrutnib and Venetolax in RR-CLL at MOASCs Spotlight On Hematology in Huntington Beach 2018.
Up Next Autoplay